The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans. (1996)
Jaques A, Opdenakker G, Rademacher T, Dwek R, Zamze S
Biochem J, 1996 vol.316:427-437
SNFG,
Text,
Oxford
taxonomy (1)
protein (1)
source (1)
structure (9)
composition (8)
disease (1)
reference (1)
site (3)
peptide (0)
- Homo sapiens (Human)
Taxonomy
- N-Linked / Complex / GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)[HexNAc(b1-4)][Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-6)[GalNAc(b1-4)GlcNAc(b1-2)]Man(a1-6)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / GalNAc(b1-4)GlcNAc(b1-2)[GalNAc(b1-4)GlcNAc(b1-?)]Man(a1-?)[GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:3 HexNAc:8 dHex:1 (avg mass : 2276.1455 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:7 dHex:1 (avg mass : 2235.0929 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
Composition
- Melanoma (DOID:1909)
Disease
- Tissue-type plasminogen activator / Homo sapiens
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1666.5605)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1666.5605)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1682.5599)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1723.6125)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1828.7029)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1869.7555)
- Melanoma (DOID:1909)
- Tissue-type plasminogen activator / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2235.0929)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2276.1455)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1641.5073)
- Melanoma (DOID:1909)
-
Tissue-type plasminogen activator / Homo sapiens
- Undefined site
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1641.5073)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2276.1455)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2235.0929)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1869.7555)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1828.7029)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1723.6125)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1682.5599)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1666.5605)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1666.5605)
